Clinical studies show that retatrutide could be the most powerful drug to be developed for the treatment of obesity
Over 80% of participants on this dose lost more than 15% of their total body weight, a benchmark that correlates with resolution of obesity-related comorbidities in clinical literature
[DOI] [PMC free article] [PubMed] [Google Scholar] 169.Wadden T.A., Bailey T.S., Billings L.K., Davies M., Frias J.P., Koroleva A., Lingvay I., O'Neil P.M., Rubino D.M., Skovgaard D., et al
Strains of these bacteria have also been linked to weight loss, though we need clinical trials to develop recommendations for probiotics and weight loss
The researchers analyzed data from a 2025 survey of 7,521 adults in the United States
We can now add sleep apnea to the growing list